Research suggests aspirin helps combat cataractsJune 03, 2004Ongoing research in the School of Animal and Microbial Sciences (AMS) at the University of Reading has helped to clarify the process of cataract, the largest cause of blindness in the world. Professor James Crabbe and his team in AMS have targeted the importance of non-steroidal anti-inflammatory drugs - such as aspirin - in helping protect against the development of cataracts. "Aspirin-like analgesics have a protective effect against retinopathy and cataract," says Professor Crabbe. "We have found that aspirin inhibits the protein cross-linking process responsible for cataract. "This accords with epidemiological evidence from people suffering from diabetes and rheumatoid arthritis and who take aspirin, and suggests that aspirin could delay the onset of cataract by 43%. Similar studies on paracetamol and ibuprofen suggest that consumption of these analgesics would halve the risk of cataract visually impairing the lens." "We have demonstrated that a Bayesian approach (the use of prior knowledge) can produce major gains in terms of the productivity and accuracy of each experiment. By developing the use of the Bayesian approach, it is possible to reduce the necessary amount of experiments and data points measured, but to increase their efficiency and cost-effectiveness. Professor Crabbe, who is Head of the School of AMS, presented his findings at a recent workshop held by AGEnet, the University's unique network for bringing together researchers, healthcare professionals, charity workers and members of the public interested in ageing, impairment and disability. The next AGEnet workshop, 'Research for a New Age: New Dimensions of Ageing' takes place on Thursday 24 June and will explore the research and practice being pursued by ageing and health specialists recently appointed to the University, and their approaches to improving the quality of life of older people. Please contact Verity Smith, the AGEnet co-ordinator by e-mail: h.v.smith@reading.ac.uk | |||||||||||||||||||||
|
Related Aspirin Current Events and Aspirin News Articles New evidence that people make aspirin's active principle -- salicylic acid Scientists in the United Kingdom are reporting new evidence that humans can make their own salicylic acid (SA) - the material formed when aspirin breaks down in the body. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA. Quintet of proteins forms new, early-warning blood test before heart attack strikes A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia. Hospital rankings: More than meets the eye Medicare's pay-for-performance program ranks and rewards hospitals according to how well they meet certain guidelines for clinical care. Aspirin does not prevent heart attacks in patients with diabetes Taking regular aspirin and antioxidant supplements does not prevent heart attacks even in high risk groups with diabetes and asymptomatic arterial disease, and aspirin should only be given to patients with established heart disease, stroke or limb arterial disease. Triple antiplatelet therapy appears superior to dual antiplatelet therapy Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents achieves greater platelet inhibition than conventional dual antiplatelet therapy. New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008 Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). Aspirin and atherosclerosis Aspirin has become one of the most widely used medications in the world, owing to its ability to reduce pain, fevers, inflammation, and blood clotting. Unusual case of a woman who suffered stroke during sex Minutes after having sexual intercourse with her boyfriend, a 35-year-old woman suddenly felt her left arm go weak. Her speech became slurred and she lost feeling on the left side of her face. More Aspirin Current Events and Aspirin News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||